Alaunos Therapeutics | ZIOP - Net Income


Alaunos Therapeutics reported $-1.01M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Amgen USD 2.38B 556M Jun/2026
AstraZeneca USD 2.51B 573M Jun/2026
Baxter International USD 126M 141M Jun/2026
Biogen USD 97.5M 222M Jun/2026
Bioline Rx USD -1.6M 635K Mar/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Celltrion KRW 8.82B 64.74M Mar/2026
Corcept Therapeutics USD 42.14M 73.9M Jun/2026
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Curis USD -24.2M 43.56M Mar/2026
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 9.02B 1.51B Jun/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
Incyte USD 585.6M 282.27M Jun/2026
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
J&J USD 5.53B 299M Jun/2026
Kangmei Pharma CNY 52.6M 69.16M Jun/2026
Karyopharm Therapeutics USD -22.39M 79.81M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Merck USD -1.34B 2.9B Jun/2026
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Novartis USD 3.26B 108M Jun/2026
Organigram Holdings CAD -921K 20.89M Mar/2026
Ovoca Bio EUR 4.42M 5.19M Dec/2025
Pfizer USD -248M 2.94B Jun/2026
Pharma Mar EUR -972K 2.5M Jun/2026
PTC Therapeutics USD -2.81M 132.16M Mar/2026
Qiagen NV USD 103.4M 35.36M Jun/2026
Regeneron Pharmaceuticals USD 1.3B 569.7M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sartorius EUR 65.9M 9.7M Jun/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
TG Therapeutics USD 7.78M 12M Jun/2026
Tilray USD -44.93M 44.61M Sep/2025
Verastem USD -36.59M 3.68M Mar/2026
Zealand Pharma A/S -394M 14.88M Mar/2026
Zz Pientze Pharmaceu CNY 349.49M 393.99M Jun/2026